If you're still searching for relief from UC symptoms, especially if other treatments haven't provided adequate control, consider a potential new treatment option for ulcerative colitis.
Study-related treatments and evaluations are provided at no cost.
Participants receive compensation for their time and travel expenses associated with study visits.
Loading video...
Our PI wants to personally reach out to you so that you are aware of this study.
We would love to welcome you in and explore what options might be a good fit.
This advanced research study is evaluating a targeted therapy designed to reduce inflammation, to assess its potential in helping achieve and maintain symptom relief in patients with active ulcerative colitis symptoms.
The study includes a 12-week initial treatment period followed by a 52-week maintenance period with an optional long-term extension. Regular clinic visits will monitor your progress throughout the study.
The study is being conducted at Access Research Institute, located at 11373 Cortez Blvd Building C, Suite 200, Brooksville, FL 34613.
Understanding the science behind this new therapy being studied for ulcerative colitis
This study medication represents a new approach to potentially treating ulcerative colitis. By targeting specific proteins that play a central role in gut inflammation, this therapy is being studied for its potential to address the chronic intestinal inflammation associated with UC.
Research has shown that certain proteins are involved in regulating inflammation in the gut and immune system. In people with UC, these pathways may contribute to the ongoing intestinal inflammation and tissue damage. By potentially blocking these inflammatory pathways, this study treatment is being evaluated for its ability to help achieve and maintain symptom relief in UC.
The study medication is a targeted therapy specifically designed to address inflammation.
Designed to block inflammatory pathways involved in UC symptoms.
It works by blocking TL1A, a protein that plays a central role in gut mucosal immunity and UC pathogenesis.
Aims to reduce the chronic intestinal inflammation associated with UC.
By blocking inflammatory pathways, the study medication may help achieve and maintain symptom relief in UC patients.
Currently being evaluated in advanced clinical research.
The study medication specifically targets inflammation pathways that are involved in UC symptoms.
Being studied for its effectiveness and safety profile.
Dr. Salman currently serves as program director for the Internal Medicine Residency Program at Oak Hill Hospital. He received his medical degree from Quaid-e-Azam University and his pre-medical training was at Sir Syed College. He then served for 13 years at Seton Hall University Internal Medicine Program at Saint Francis Medical Center in New Jersey where he completed his internal medicine residency and was a chief resident.
Internal Medicine
Consumer Research Council of America 2010, 2011, 2014 & 2015
Clinical Experience
"As a doctor, I see how challenging ulcerative colitis can be. This study is a way for us to explore potential options that may help people feel better and live healthier lives. Every person who joins helps us move one step closer to better care in the future."
Participating in this UC study offers several potential advantages for patients with moderately to severely active ulcerative colitis.
This study is evaluating a targeted therapy designed to reduce inflammation, to see if it can help achieve and maintain symptom relief in active ulcerative colitis.
All study-related care, study medication, and clinic visits are provided at no cost to eligible participants.
Participants receive compensation for their time and travel expenses associated with study visits.
Led by gastroenterology specialists, our experienced research team provides comprehensive UC care and monitoring throughout the study period.
Ready to join our clinical study? It's simple. Just follow these easy steps.
Schedule your first chat with our friendly team. We'll talk about your health and see if this study is a good fit for you. We'll go over your health background, current care, and understand your condition better.
Next, we'll do a quick check-up to make sure the study is right for your specific needs. We'll walk you through everything about the study – the potential benefits and risks, what to expect, and answer all your questions.
If you feel ready to move forward, you'll review and sign the informed consent form. This important paper explains everything: what happens in the study, the timeline, and your rights as a participant.
Embark on your study journey and begin your first treatment session! You'll get a personalized treatment plan made just for you, along with a clear schedule for your participation.
Find answers to common questions about our clinical research study.
Have more questions about the study?
Call Our Friendly TeamFind out if you're a good fit for this investigational study. Our team will contact you within 24 hours.
Voluntary Participation
We can only accept a limited number of participants for this investigational study.
No-Cost Evaluation
Your consultation and all study-related care is provided at no cost to qualified participants.
No Obligation
The consultation is informational only - you decide if this investigational study is right for you.
Visit our clinic location in Brooksville, FL for your consultation and study visits.
11373 Cortez Blvd Building C, Suite 200
Brooksville, FL 34613
Monday-Friday
9am-5pm
Free parking
Wheelchair accessible